Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease. - Melchior, Benoît; Mittapalli, Gopi Kumar; Lai, Carolyn; Duong‐Polk, Karen; Stewart, Joshua; Güner, Bora; Hofilena, Brian; Tjitro, Amanda; Anderson, Scott D.; Herman, David S.; Dellamary, Luis; Swearingen, Christopher J.; et al. (Aging Cell, 2019)